• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以治愈为目的的手术与日本人群中头皮和面部皮肤血管肉瘤患者的长期生存相关 - 38 例未经治疗病例的回顾性研究。

Surgery with curative intent is associated with prolonged survival in patients with cutaneous angiosarcoma of the scalp and face -a retrospective study of 38 untreated cases in the Japanese population.

机构信息

Department of Dermatologic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan; Department of Dermatology, Saitama Cancer Center, 780 Komuro, Ina, Kitaadachi-gun, Saitama 362-0806, Japan.

Department of Dermatologic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

出版信息

Eur J Surg Oncol. 2018 Jun;44(6):823-829. doi: 10.1016/j.ejso.2018.02.246. Epub 2018 Mar 6.

DOI:10.1016/j.ejso.2018.02.246
PMID:29555155
Abstract

BACKGROUND

In patients with cutaneous angiosarcoma of the scalp and face, the validity of surgery remains controversial, because of the potentially diffuse nature of involvement and difficulty in obtaining negative margins.

OBJECTIVE

To evaluate the survival benefit of surgery as a primary treatment.

PATIENTS AND METHODS

Fifty-one patients with primary cutaneous angiosarcoma of the scalp and face presenting with locoregional involvement were referred to National Cancer Center Hospital, Tokyo, Japan, between May 1982 and March 2013. Data of those patients in whom the diagnosis had been confirmed histologically and the primary treatments had been initiated at our center were analysed retrospectively. Only untreated cases were selected with aim to evaluate actual survival benefit of surgery as a primary treatment.

RESULTS

Of the 51 patients, 38 were found to be eligible for inclusion in this analysis; of these 38 patients, 29 (29/38 = 76.3%) patients had tumour diameter > 5 cm, and 29 underwent surgery with curative intent (curative-intent surgery) as the initial treatment. Histologically positive margins were found in 10 patients. Multivariate analysis identified curative-intent surgery as being significantly associated with improved overall survival (OS; HR = 0.26; 95% CI, 0.10-0.63). In the Surgery group, neither negative margins nor combined-modality treatment had any significant influence on the OS.

CONCLUSION

Removal of primary tumour with curative-intent surgery may be a valid treatment option even for patients with primary cutaneous angiosarcoma of the scalp and face larger than 5 cm in size, regardless of the histological surgical margin status.

摘要

背景

头皮和面部皮肤血管肉瘤患者的手术有效性存在争议,因为病变可能呈弥漫性且难以获得阴性切缘。

目的

评估手术作为初始治疗的生存获益。

患者和方法

1982 年 5 月至 2013 年 3 月期间,51 例头皮和面部原发性皮肤血管肉瘤局部区域受累患者转诊至日本东京国家癌症中心医院。对在我院确诊并接受初始治疗的患者进行回顾性数据分析。本研究仅选择未经治疗的病例,旨在评估手术作为初始治疗的实际生存获益。

结果

51 例患者中,有 38 例符合纳入本分析的条件;这 38 例患者中,29 例(29/38=76.3%)肿瘤直径>5cm,29 例患者接受了以治愈为目的的手术(根治性手术)作为初始治疗。10 例患者的切缘阳性。多因素分析显示,以治愈为目的的手术与总生存(OS)改善显著相关(HR=0.26;95%CI,0.10-0.63)。在手术组中,阴性切缘或联合治疗对 OS 均无显著影响。

结论

对于直径大于 5cm 的头皮和面部皮肤血管肉瘤患者,即使切缘阳性,根治性手术切除原发肿瘤也可能是一种有效的治疗选择。

相似文献

1
Surgery with curative intent is associated with prolonged survival in patients with cutaneous angiosarcoma of the scalp and face -a retrospective study of 38 untreated cases in the Japanese population.以治愈为目的的手术与日本人群中头皮和面部皮肤血管肉瘤患者的长期生存相关 - 38 例未经治疗病例的回顾性研究。
Eur J Surg Oncol. 2018 Jun;44(6):823-829. doi: 10.1016/j.ejso.2018.02.246. Epub 2018 Mar 6.
2
Survival outcomes for cutaneous angiosarcoma of the scalp versus face.头皮与面部皮肤血管肉瘤的生存结果。
Head Neck. 2017 Jun;39(6):1205-1211. doi: 10.1002/hed.24747. Epub 2017 Apr 11.
3
Angiosarcoma of the scalp and face: the Mayo Clinic experience.头皮和面部血管肉瘤:梅奥诊所的经验
JAMA Otolaryngol Head Neck Surg. 2015 Apr;141(4):335-40. doi: 10.1001/jamaoto.2014.3584.
4
Treatment and prognosis of angiosarcoma of the scalp and face: a retrospective analysis of 48 patients.头皮和面部血管肉瘤的治疗和预后:48 例回顾性分析。
Br J Radiol. 2012 Nov;85(1019):e1127-33. doi: 10.1259/bjr/31655219. Epub 2012 Jul 17.
5
Patterns of Care and Survival of Cutaneous Angiosarcoma of the Head and Neck.头颈部皮肤血管肉瘤的治疗模式和生存情况。
Otolaryngol Head Neck Surg. 2020 Jun;162(6):881-887. doi: 10.1177/0194599820905495. Epub 2020 Feb 11.
6
Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp.面部和头皮皮肤血管肉瘤的明确治疗后的结果。
Head Neck. 2011 May;33(5):661-7. doi: 10.1002/hed.21513. Epub 2010 Oct 19.
7
Treatment of cutaneous angiosarcoma of the scalp and face in Chinese patients: local experience at a regional hospital in Hong Kong.中国患者头皮和面部皮肤血管肉瘤的治疗:香港一家地区医院的本地经验。
Hong Kong Med J. 2018 Feb;24(1):25-31. doi: 10.12809/hkmj176813. Epub 2018 Jan 12.
8
Cutaneous angiosarcoma of the scalp: a multidisciplinary approach.头皮皮肤血管肉瘤:多学科治疗方法
Cancer. 2003 Oct 15;98(8):1716-26. doi: 10.1002/cncr.11667.
9
Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy.采用根治性放疗加重组白细胞介素-2免疫疗法治疗头皮血管肉瘤。
Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1446-53. doi: 10.1016/j.ijrobp.2004.08.008.
10
The Management and Prognosis of Facial and Scalp Angiosarcoma: A Retrospective Analysis of 15 Patients.面部和头皮血管肉瘤的管理与预后:15例患者的回顾性分析
Ann Plast Surg. 2019 Jul;83(1):55-62. doi: 10.1097/SAP.0000000000001865.

引用本文的文献

1
Case Report: A novel chemotherapy-free regimen combined with photodynamic therapy, target therapy, and immunotherapy in a geriatric male with huge recurrent scalp and facial angiosarcoma: a report of an extremely rare case and literature review.病例报告:一名老年男性复发性巨大头皮和面部血管肉瘤患者采用新型无化疗方案联合光动力疗法、靶向治疗和免疫治疗:1例极其罕见病例报告及文献综述
Front Immunol. 2025 Apr 29;16:1556493. doi: 10.3389/fimmu.2025.1556493. eCollection 2025.
2
A 37-Year Retrospective Analysis Reveals a High Rate of Cutaneous Angiosarcoma of the Scalp in Okinawa, Japan.一项37年的回顾性分析显示,日本冲绳头皮皮肤血管肉瘤的发病率很高。
Cancer Sci. 2025 Apr;116(4):1059-1067. doi: 10.1111/cas.16453. Epub 2025 Jan 16.
3
Cutaneous head and neck angiosarcoma: The 30-year UCLA experience.
皮肤头颈部血管肉瘤:加州大学洛杉矶分校30年的经验
Laryngoscope Investig Otolaryngol. 2023 Oct 17;8(6):1557-1563. doi: 10.1002/lio2.1173. eCollection 2023 Dec.
4
Recurrence of scalp angiosarcoma after multiple surgeries: A case report and literature review.多次手术后头皮血管肉瘤复发:一例报告及文献复习
Oncol Lett. 2023 Oct 31;26(6):536. doi: 10.3892/ol.2023.14122. eCollection 2023 Dec.
5
Clinical outcomes of scalp or face angiosarcoma treatment with intensity-modulated radiotherapy: a multicenter study.头皮或面部血管肉瘤调强放疗的临床疗效:多中心研究。
J Radiat Res. 2024 Jan 19;65(1):78-86. doi: 10.1093/jrr/rrad089.
6
Utility of Multimodal Treatment Protocols in the Management of Scalp Cutaneous Angiosarcoma.多模式治疗方案在头皮皮肤血管肉瘤管理中的效用
Plast Reconstr Surg Glob Open. 2023 Mar 3;11(3):e4827. doi: 10.1097/GOX.0000000000004827. eCollection 2023 Mar.
7
Clinical significance of local control of primary tumour in definitive radiotherapy for scalp angiosarcomas.根治性放疗头皮血管肉瘤中肿瘤局部控制的临床意义。
Skin Res Technol. 2023 Jan;29(1):e13243. doi: 10.1111/srt.13243. Epub 2022 Nov 20.
8
Prognostic factor analysis of definitive radiotherapy using intensity-modulated radiation therapy and volumetric modulated arc therapy with boluses for scalp angiosarcomas.使用调强放疗和容积旋转调强弧形治疗技术并使用填充物治疗头皮血管肉瘤的预后因素分析。
Sci Rep. 2022 Mar 14;12(1):4355. doi: 10.1038/s41598-022-08362-2.
9
The Effectiveness of Different Treatment Modalities of Cutaneous Angiosarcoma: Results From Meta-Analysis and Observational Data From SEER Database.皮肤血管肉瘤不同治疗方式的有效性:来自荟萃分析和监测、流行病学与最终结果(SEER)数据库观察数据的结果
Front Oncol. 2021 Feb 25;11:627113. doi: 10.3389/fonc.2021.627113. eCollection 2021.
10
Prognostic Determinants Analysis and Nomogram for Bone Malignant Vascular Tumors: A Surveillance, Epidemiology and End Results (SEER) Analysis.骨恶性血管肿瘤的预后因素分析和列线图:监测、流行病学和最终结果(SEER)分析。
Med Sci Monit. 2020 Jul 10;26:e923305. doi: 10.12659/MSM.923305.